Quick Answer
STANDARD BIOTOOLS INC. reported Stockholders Equity of $424.29 million for fiscal year 2025.
STANDARD BIOTOOLS INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $424.29M | -10.1% |
| 2024 | $471.72M | +418.6% |
| 2023 | -$148.05M | -81.7% |
| 2022 | -$81.47M | -186.1% |
| 2021 | $94.60M | -32.0% |
| 2020 | $139.05M | -9.5% |
| 2019 | $153.61M | +113.0% |
| 2018 | $72.12M | +133.1% |
| 2017 | $30.93M | -41.9% |
| 2016 | $53.23M | -53.7% |
| 2015 | $114.90M | -23.6% |
| 2014 | $150.42M | +56.0% |
| 2013 | $96.41M | -4.2% |
| 2012 | $100.66M | +76.9% |
| 2011 | $56.90M | +130.1% |
| 2010 | -$189.17M | -9.0% |
| 2009 | -$173.62M | -9.7% |
| 2008 | -$158.34M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $399.66M | -18.3% | -5.9% |
| June 30, 2025 | $424.54M | -16.8% | -6.6% |
| March 31, 2025 | $454.60M | -21.3% | -3.6% |
| December 31, 2024 | $471.72M | +418.6% | -3.6% |
| September 30, 2024 | $489.33M | +471.5% | -4.1% |
| June 30, 2024 | $510.26M | +550.0% | -11.6% |
| March 31, 2024 | $577.32M | +694.2% | +489.9% |
| December 31, 2023 | -$148.05M | -81.7% | -12.4% |
- STANDARD BIOTOOLS INC. showed a decrease of -10.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, STANDARD BIOTOOLS INC.’s stockholders equity has grown by 368.0% (from -$158.34 million to $424.29 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: